Molecular Formula: C172H265N43O51
Molecular Weight: 3751.202
EINECS: 810-818-7
Package: 100 g / 1 kg / 25 kg, customized.
Worldwide Delivery
Email:
sales@intopchemical.comPhone:
+8617638138100Lilalutide is a long-acting glucagon like peptide-1 (GLP-1) receptor agonist, which is an analog of GLP-1 used to treat diabetes, and is commonly used in the study of type 2 diabetes (T2DM). GLP-1 is a peptide chain secreted by intestinal L cells, consisting of 31 amino acids. It is highly functional, hypoglycemic, and safe. Among them, the homology between liraglutide and natural GLP-1 is about 97%.
1. Treatment of type 2 diabetes:
Liraglutide promotes insulin secretion and inhibits glucagon secretion by simulating the effects of natural GLP-1, thereby lowering blood sugar levels.
2. Treatment of obesity:
Liraglutide can suppress appetite and increase satiety, thereby helping patients reduce food intake and achieve the goal of weight loss.
3. Research on polycystic ovary syndrome (PCOS):
Liraglutide also has certain applications in the treatment and research of PCOS, which may be related to its improvement of insulin resistance and obesity.
100 g / 1 kg / 25 kg, customized.
Preserve in tight, light-resistant containers. Store between 2°C and 8 °C.
|
Apperance |
White powder |
|
Purity |
≥98% |
|
Target |
GLP-1 receptor |
|
Pathway |
GPCR/G Protein |
|
Solubility |
Soluble in ammonia water, alkaline (weak base) solution, etc.; soluble in water under alkaline environment |
